{"transactions":[{"id":4619336,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-09-16T20:20:58.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":85000,"derivative":{"exercise_price":27.99,"expiration_date":"2036-09-13","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001823381-26-000014","document":"form4-09162026_080954.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000182338126000014/form4-09162026_080954.xml","form_type":"4"}},{"id":4619335,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":22513,"kind":"person","name":"Brottem John L.","position":1,"cik":"0001823381","reported_name":"Brottem John L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-09-16T20:20:58.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":29000,"source":{"system":"sec-edgar","filing":"0001823381-26-000014","document":"form4-09162026_080954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000182338126000014/form4-09162026_080954.xml","form_type":"4"}},{"id":2382,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":1792,"kind":"person","name":"RAGUSA ROBERT P","position":1,"cik":"0001222644","reported_name":"RAGUSA ROBERT P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-03T20:27:52.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":25599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to the option will vest on September 1, 2027 and the remainder of the shares subject to the grant will vest in equal monthly installments thereafter through September 1, 2029, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":25599,"derivative":{"exercise_price":29.36,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":25599},"source":{"system":"sec-edgar","filing":"0001222644-26-000004","document":"form4-09032026_080949.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000122264426000004/form4-09032026_080949.xml","form_type":"4"}},{"id":2381,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":1792,"kind":"person","name":"RAGUSA ROBERT P","position":1,"cik":"0001222644","reported_name":"RAGUSA ROBERT P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-03T20:27:52.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":5686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs vest in equal annual installments over 3 years measured from September 1, 2026, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":5686,"source":{"system":"sec-edgar","filing":"0001222644-26-000004","document":"form4-09032026_080949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000122264426000004/form4-09032026_080949.xml","form_type":"4"}},{"id":802902,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":4648194,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held of record by Qiming Venture Partners VIII-HC, L.P. (\"QVP VIII-HC\"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":1922329},"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802901,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":3882451,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held of record by Qiming Venture Partners VIII Investments, LLC (\"QVP VIII LLC\"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":1605645},"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802900,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":4222738,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held of record by Qiming Venture Partners VI, L.P., (\"Qiming Venture Partners VI\"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":1859366},"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802899,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":113625,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held of record by Qiming Managing Directors Fund VI, L.P. (\"Qiming Managing Directors\"). Qiming Corporate GP VI, Ltd. (\"Qiming Corporate\") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":50031},"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802898,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-4 Preferred Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":5738971,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held of record by Qiming Venture Partners VI, L.P., (\"Qiming Venture Partners VI\"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":2373437},"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802897,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-4 Preferred Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":154425,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held of record by Qiming Managing Directors Fund VI, L.P. (\"Qiming Managing Directors\"). Qiming Corporate GP VI, Ltd. (\"Qiming Corporate\") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":63864},"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802896,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-3 Preferred Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":6404332,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held of record by Qiming Venture Partners VI, L.P., (\"Qiming Venture Partners VI\"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":2648607},"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802895,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-3 Preferred Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":172328,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held of record by Qiming Managing Directors Fund VI, L.P. (\"Qiming Managing Directors\"). Qiming Corporate GP VI, Ltd. (\"Qiming Corporate\") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":71268},"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802894,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":1922329,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held of record by Qiming Venture Partners VIII-HC, L.P. (\"QVP VIII-HC\"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":1922329,"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802893,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":1605645,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held of record by Qiming Venture Partners VIII Investments, LLC (\"QVP VIII LLC\"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":1605645,"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802892,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":6881410,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held of record by Qiming Venture Partners VI, L.P., (\"Qiming Venture Partners VI\"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":6881410,"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802891,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":185163,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held of record by Qiming Managing Directors Fund VI, L.P. (\"Qiming Managing Directors\"). Qiming Corporate GP VI, Ltd. (\"Qiming Corporate\") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":185163,"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802890,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":1922329,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held of record by Qiming Venture Partners VIII-HC, L.P. (\"QVP VIII-HC\"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802889,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":1605645,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held of record by Qiming Venture Partners VIII Investments, LLC (\"QVP VIII LLC\"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802888,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":6881410,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held of record by Qiming Venture Partners VI, L.P., (\"Qiming Venture Partners VI\"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802887,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":185163,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held of record by Qiming Managing Directors Fund VI, L.P. (\"Qiming Managing Directors\"). Qiming Corporate GP VI, Ltd. (\"Qiming Corporate\") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802886,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":1922329,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held of record by Qiming Venture Partners VIII-HC, L.P. (\"QVP VIII-HC\"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":1922329,"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802885,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":1605645,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held of record by Qiming Venture Partners VIII Investments, LLC (\"QVP VIII LLC\"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":1605645,"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802884,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":6881410,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held of record by Qiming Venture Partners VI, L.P., (\"Qiming Venture Partners VI\"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":6881410,"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":802883,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51640,"kind":"organization","name":"Qiming Corporate GP VI, Ltd.","position":1,"cik":"0002059127","reported_name":"Qiming Corporate GP VI, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51641,"kind":"organization","name":"Qiming Managing Directors Fund VI, L.P.","position":2,"cik":"0001733282","reported_name":"Qiming Managing Directors Fund VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51642,"kind":"organization","name":"Qiming Venture Partners VI, L.P.","position":3,"cik":"0001733278","reported_name":"Qiming Venture Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51643,"kind":"organization","name":"Qiming GP VIII, LLC","position":4,"cik":"0002129740","reported_name":"Qiming GP VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51644,"kind":"organization","name":"Qiming Venture Partners VIII Investments, LLC","position":5,"cik":"0002129618","reported_name":"Qiming Venture Partners VIII Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51645,"kind":"organization","name":"Qiming GP VIII-HC, LLC","position":6,"cik":"0002129671","reported_name":"Qiming GP VIII-HC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51646,"kind":"organization","name":"Qiming Venture Partners VIII-HC, L.P.","position":7,"cik":"0001910025","reported_name":"Qiming Venture Partners VIII-HC, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-22T16:16:41.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":185163,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held of record by Qiming Managing Directors Fund VI, L.P. (\"Qiming Managing Directors\"). Qiming Corporate GP VI, Ltd. (\"Qiming Corporate\") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein."}],"balance_after":185163,"source":{"system":"sec-edgar","filing":"0001231919-26-000392","document":"form4-04222026_080434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1733278/000123191926000392/form4-04222026_080434.xml","form_type":"4"}},{"id":804657,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"price":0,"reported_value":3927259.98,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of July 8, 2027. The principal amount of the convertible note was automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to the initial public offering price of the Issuer's Common Stock multiplied by 0.85."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of July 8, 2027. The principal amount of the convertible note was automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to the initial public offering price of the Issuer's Common Stock multiplied by 0.85."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of July 8, 2027. The principal amount of the convertible note was automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to the initial public offering price of the Issuer's Common Stock multiplied by 0.85."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The securities are held by Illumina Innovation Fund III, L.P. (\"IIF III\"). Illumina Innovation Fund III GP, L.L.C. (\"IIF III GP\") is the general partner of IIF III. Mr. Naclerio, a member of the Issuer's board of directors, is the sole managing member of IIF III GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF III. Each of IIF III GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF III, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":271782},"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804656,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"price":0,"reported_value":5000000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of July 8, 2027. The principal amount of the convertible note was automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to the initial public offering price of the Issuer's Common Stock multiplied by 0.85."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of July 8, 2027. The principal amount of the convertible note was automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to the initial public offering price of the Issuer's Common Stock multiplied by 0.85."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of July 8, 2027. The principal amount of the convertible note was automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to the initial public offering price of the Issuer's Common Stock multiplied by 0.85."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Illumina Innovation Fund II, L.P. (\"IIF II\"). Illumina Innovation Fund II GP, L.L.C. (\"IIF II GP\") is the general partner of IIF II. Nicholas Naclerio (\"Mr. Naclerio\"), a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":346020},"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804655,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":5037783,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1-for-2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1-for-2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1-for-2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Illumina Innovation Fund II, L.P. (\"IIF II\"). Illumina Innovation Fund II GP, L.L.C. (\"IIF II GP\") is the general partner of IIF II. Nicholas Naclerio (\"Mr. Naclerio\"), a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":2083450},"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804654,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":2094266,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series B Preferred Stock is convertible into shares of Class B Common Stock on a 1-for-2.271 basis and has no expiration date. The Series B Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series B Preferred Stock is convertible into shares of Class B Common Stock on a 1-for-2.271 basis and has no expiration date. The Series B Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the IPO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series B Preferred Stock is convertible into shares of Class B Common Stock on a 1-for-2.271 basis and has no expiration date. The Series B Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Illumina Innovation Fund II, L.P. (\"IIF II\"). Illumina Innovation Fund II GP, L.L.C. (\"IIF II GP\") is the general partner of IIF II. Nicholas Naclerio (\"Mr. Naclerio\"), a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":922152},"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804653,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-4 Preferred Stock","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":2862507,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1-for-2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1-for-2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1-for-2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Illumina Innovation Fund II, L.P. (\"IIF II\"). Illumina Innovation Fund II GP, L.L.C. (\"IIF II GP\") is the general partner of IIF II. Nicholas Naclerio (\"Mr. Naclerio\"), a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":1183832},"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804652,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-3 Preferred Stock","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":3194377,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1-for-2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1-for-2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1-for-2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Illumina Innovation Fund II, L.P. (\"IIF II\"). Illumina Innovation Fund II GP, L.L.C. (\"IIF II GP\") is the general partner of IIF II. Nicholas Naclerio (\"Mr. Naclerio\"), a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":1321082},"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804651,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"purchase","planned":false,"acquired":true,"shares":235294,"price":17,"value":3999998.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The securities are held by Illumina Innovation Fund III, L.P. (\"IIF III\"). Illumina Innovation Fund III GP, L.L.C. (\"IIF III GP\") is the general partner of IIF III. Mr. Naclerio, a member of the Issuer's board of directors, is the sole managing member of IIF III GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF III. Each of IIF III GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF III, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":507076,"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804650,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":271782,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of July 8, 2027. The principal amount of the convertible note was automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to the initial public offering price of the Issuer's Common Stock multiplied by 0.85."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of July 8, 2027. The principal amount of the convertible note was automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to the initial public offering price of the Issuer's Common Stock multiplied by 0.85."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The securities are held by Illumina Innovation Fund III, L.P. (\"IIF III\"). Illumina Innovation Fund III GP, L.L.C. (\"IIF III GP\") is the general partner of IIF III. Mr. Naclerio, a member of the Issuer's board of directors, is the sole managing member of IIF III GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF III. Each of IIF III GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF III, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":271782,"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804649,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":346020,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of July 8, 2027. The principal amount of the convertible note was automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to the initial public offering price of the Issuer's Common Stock multiplied by 0.85."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of July 8, 2027. The principal amount of the convertible note was automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to the initial public offering price of the Issuer's Common Stock multiplied by 0.85."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Illumina Innovation Fund II, L.P. (\"IIF II\"). Illumina Innovation Fund II GP, L.L.C. (\"IIF II GP\") is the general partner of IIF II. Nicholas Naclerio (\"Mr. Naclerio\"), a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":5856536,"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804648,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":5510516,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Illumina Innovation Fund II, L.P. (\"IIF II\"). Illumina Innovation Fund II GP, L.L.C. (\"IIF II GP\") is the general partner of IIF II. Nicholas Naclerio (\"Mr. Naclerio\"), a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":5510516,"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804647,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":5510516,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Illumina Innovation Fund II, L.P. (\"IIF II\"). Illumina Innovation Fund II GP, L.L.C. (\"IIF II GP\") is the general partner of IIF II. Nicholas Naclerio (\"Mr. Naclerio\"), a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804646,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":922152,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The Series B Preferred Stock is convertible into shares of Class B Common Stock on a 1-for-2.271 basis and has no expiration date. The Series B Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B Preferred Stock is convertible into shares of Class B Common Stock on a 1-for-2.271 basis and has no expiration date. The Series B Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Illumina Innovation Fund II, L.P. (\"IIF II\"). Illumina Innovation Fund II GP, L.L.C. (\"IIF II GP\") is the general partner of IIF II. Nicholas Naclerio (\"Mr. Naclerio\"), a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":5510516,"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804645,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51958,"kind":"organization","name":"Illumina Innovation Fund II GP, L.L.C.","position":1,"cik":"0001779219","reported_name":"Illumina Innovation Fund II GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51959,"kind":"organization","name":"Illumina Innovation Fund II, L.P.","position":2,"cik":"0001779218","reported_name":"Illumina Innovation Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51960,"kind":"organization","name":"Illumina Innovation Fund III GP, L.L.C.","position":3,"cik":"0002032563","reported_name":"Illumina Innovation Fund III GP, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51961,"kind":"organization","name":"Illumina Innovation Fund III, L.P.","position":4,"cik":"0002032562","reported_name":"Illumina Innovation Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51914,"kind":"person","name":"Naclerio Nicholas","position":5,"cik":"0001534166","reported_name":"Naclerio Nicholas","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-21T00:45:36.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":4588364,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1-for-2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock are convertible into shares of Class B Common Stock on a 1-for-2.418 basis and have no expiration date. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock in connection with the closing of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Illumina Innovation Fund II, L.P. (\"IIF II\"). Illumina Innovation Fund II GP, L.L.C. (\"IIF II GP\") is the general partner of IIF II. Nicholas Naclerio (\"Mr. Naclerio\"), a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":4588364,"source":{"system":"sec-edgar","filing":"0001193125-26-164634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032562/000119312526164634/ownership.xml","form_type":"4"}},{"id":804248,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:37:51.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":140612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":140612,"derivative":{"exercise_price":7.6,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":140612},"source":{"system":"sec-edgar","filing":"0001823563-26-000013","document":"form4-04212026_120444.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823563/000182356326000013/form4-04212026_120444.xml","form_type":"4"}},{"id":804247,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":10313,"kind":"person","name":"Chambers Rebecca","position":1,"cik":"0001823563","reported_name":"Chambers Rebecca","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:37:51.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":140612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":7.6,"expiration_date":"2036-01-14","underlying":"Class B Common Stock","underlying_shares":140612},"source":{"system":"sec-edgar","filing":"0001823563-26-000013","document":"form4-04212026_120444.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823563/000182356326000013/form4-04212026_120444.xml","form_type":"4"}},{"id":804414,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":36080,"kind":"person","name":"Witney Frank","position":1,"cik":"0001455312","reported_name":"Witney Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:37:03.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":124069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":124069,"derivative":{"exercise_price":7.6,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":124069},"source":{"system":"sec-edgar","filing":"0001455312-26-000004","document":"form4-04212026_120458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1455312/000145531226000004/form4-04212026_120458.xml","form_type":"4"}},{"id":804413,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":36080,"kind":"person","name":"Witney Frank","position":1,"cik":"0001455312","reported_name":"Witney Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:37:03.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":124069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":7.6,"expiration_date":"2036-01-14","underlying":"Class B Common Stock","underlying_shares":124069},"source":{"system":"sec-edgar","filing":"0001455312-26-000004","document":"form4-04212026_120458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1455312/000145531226000004/form4-04212026_120458.xml","form_type":"4"}},{"id":804412,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":36080,"kind":"person","name":"Witney Frank","position":1,"cik":"0001455312","reported_name":"Witney Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:37:03.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":33085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":33085,"derivative":{"exercise_price":3.1,"expiration_date":"2035-04-15","underlying":"Common Stock","underlying_shares":33085},"source":{"system":"sec-edgar","filing":"0001455312-26-000004","document":"form4-04212026_120458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1455312/000145531226000004/form4-04212026_120458.xml","form_type":"4"}},{"id":804411,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":36080,"kind":"person","name":"Witney Frank","position":1,"cik":"0001455312","reported_name":"Witney Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:37:03.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":33085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.1,"expiration_date":"2035-04-15","underlying":"Class B Common Stock","underlying_shares":33085},"source":{"system":"sec-edgar","filing":"0001455312-26-000004","document":"form4-04212026_120458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1455312/000145531226000004/form4-04212026_120458.xml","form_type":"4"}},{"id":804410,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":36080,"kind":"person","name":"Witney Frank","position":1,"cik":"0001455312","reported_name":"Witney Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:37:03.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":49627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":49627,"derivative":{"exercise_price":0.59,"expiration_date":"2031-04-20","underlying":"Common Stock","underlying_shares":49627},"source":{"system":"sec-edgar","filing":"0001455312-26-000004","document":"form4-04212026_120458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455312/000145531226000004/form4-04212026_120458.xml","form_type":"4"}},{"id":804409,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":36080,"kind":"person","name":"Witney Frank","position":1,"cik":"0001455312","reported_name":"Witney Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:37:03.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":49627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.59,"expiration_date":"2031-04-20","underlying":"Class B Common Stock","underlying_shares":49627},"source":{"system":"sec-edgar","filing":"0001455312-26-000004","document":"form4-04212026_120458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455312/000145531226000004/form4-04212026_120458.xml","form_type":"4"}},{"id":804216,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":16333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":16333,"derivative":{"exercise_price":7.6,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":16333},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804215,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":16333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":7.6,"expiration_date":"2036-01-14","underlying":"Class B Common Stock","underlying_shares":16333},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804214,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":5775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Twenty-five percent of the shares subject to the option vest on January 1, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":5775,"derivative":{"exercise_price":3.1,"expiration_date":"2035-04-08","underlying":"Common Stock","underlying_shares":5775},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804213,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":5775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Twenty-five percent of the shares subject to the option vest on January 1, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.1,"expiration_date":"2035-04-08","underlying":"Class B Common Stock","underlying_shares":5775},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804212,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":8532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":8532,"derivative":{"exercise_price":3.34,"expiration_date":"2035-01-15","underlying":"Common Stock","underlying_shares":8532},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804211,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":8532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.34,"expiration_date":"2035-01-15","underlying":"Class B Common Stock","underlying_shares":8532},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804210,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":206782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":206782,"derivative":{"exercise_price":3.34,"expiration_date":"2035-01-15","underlying":"Common Stock","underlying_shares":206782},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804209,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":206782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.34,"expiration_date":"2035-01-15","underlying":"Class B Common Stock","underlying_shares":206782},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804208,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":10686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2024, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":10686,"derivative":{"exercise_price":3.34,"expiration_date":"2034-04-16","underlying":"Common Stock","underlying_shares":10686},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804207,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":10686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2024, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.34,"expiration_date":"2034-04-16","underlying":"Class B Common Stock","underlying_shares":10686},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804206,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":8726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":8726,"derivative":{"exercise_price":2.28,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":8726},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804205,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":8726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.28,"expiration_date":"2032-02-15","underlying":"Class B Common Stock","underlying_shares":8726},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804204,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":29357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":29357,"derivative":{"exercise_price":0.59,"expiration_date":"2031-04-20","underlying":"Common Stock","underlying_shares":29357},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804203,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":29357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.59,"expiration_date":"2031-04-20","underlying":"Class B Common Stock","underlying_shares":29357},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804202,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":163358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":163358,"derivative":{"exercise_price":17,"expiration_date":"2036-04-15","underlying":"Common Stock","underlying_shares":163358},"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804201,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":37220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\").  The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":491803,"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804200,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":454583,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."}],"balance_after":454583,"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804199,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51878,"kind":"person","name":"White Timothy Ogden","position":1,"cik":"0002126704","reported_name":"White Timothy Ogden","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Class B Common Stock","published_at":"2026-04-21T00:35:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":454583,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0002126704-26-000004","document":"form4-04212026_120426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/form4-04212026_120426.xml","form_type":"4"}},{"id":804198,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right  to Buy)","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":12190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":12190,"derivative":{"exercise_price":7.6,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":12190},"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804197,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":12190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":7.6,"expiration_date":"2036-01-14","underlying":"Class B Common Stock","underlying_shares":12190},"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804196,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":300883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":300883,"derivative":{"exercise_price":3.34,"expiration_date":"2035-01-15","underlying":"Common Stock","underlying_shares":300883},"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804195,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":300883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.34,"expiration_date":"2035-01-15","underlying":"Class B Common Stock","underlying_shares":300883},"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804194,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Series A-1 Preferred Stock","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":176160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A-1 Preferred Stock is convertible into shares of Class B Common Stock on a 1:2.418 basis and has no expiration date. The Series A-1 Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A-1 Preferred Stock is convertible into shares of Class B Common Stock on a 1:2.418 basis and has no expiration date. The Series A-1 Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A-1 Preferred Stock is convertible into shares of Class B Common Stock on a 1:2.418 basis and has no expiration date. The Series A-1 Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the IPO."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":72853},"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804193,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Founders Preferred Stock","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":73200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date.  The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date.  The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date.  The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":73200},"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804192,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":247311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date.  The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date.  The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date.  The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":247311},"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804191,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":163358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":163358,"derivative":{"exercise_price":17,"expiration_date":"2036-04-15","underlying":"Common Stock","underlying_shares":163358},"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804190,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":37220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents the grant of restricted stock units (\"RSUs\"). The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":760105,"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804189,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":722885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."}],"balance_after":722885,"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804188,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class B Common Stock","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":722885,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804187,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class B Common Stock","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":72853,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Series A-1 Preferred Stock is convertible into shares of Class B Common Stock on a 1:2.418 basis and has no expiration date. The Series A-1 Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A-1 Preferred Stock is convertible into shares of Class B Common Stock on a 1:2.418 basis and has no expiration date. The Series A-1 Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the IPO."}],"balance_after":722885,"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804186,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51877,"kind":"person","name":"Chen Shiping","position":1,"cik":"0002126944","reported_name":"Chen Shiping","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class B Common Stock","published_at":"2026-04-21T00:34:44.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":320511,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date.  The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date.  The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."}],"balance_after":650032,"source":{"system":"sec-edgar","filing":"0002126944-26-000004","document":"form4-04212026_120439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/form4-04212026_120439.xml","form_type":"4"}},{"id":804185,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option ((Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":42334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":42334,"derivative":{"exercise_price":7.6,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":42334},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804184,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":42334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":7.6,"expiration_date":"2036-01-14","underlying":"Class B Common Stock","underlying_shares":42334},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804183,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":37086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":37086,"derivative":{"exercise_price":3.34,"expiration_date":"2035-01-15","underlying":"Common Stock","underlying_shares":37086},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804182,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":37086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.34,"expiration_date":"2035-01-15","underlying":"Class B Common Stock","underlying_shares":37086},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804181,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":1033912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":1033912,"derivative":{"exercise_price":3.34,"expiration_date":"2035-01-15","underlying":"Common Stock","underlying_shares":1033912},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804180,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":1033912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.34,"expiration_date":"2035-01-15","underlying":"Class B Common Stock","underlying_shares":1033912},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804179,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2024, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":27700,"derivative":{"exercise_price":3.34,"expiration_date":"2034-04-16","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804178,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2024, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.34,"expiration_date":"2034-04-16","underlying":"Class B Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804177,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":20023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":20023,"derivative":{"exercise_price":1.53,"expiration_date":"2033-04-24","underlying":"Common Stock","underlying_shares":20023},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804176,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":20023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.53,"expiration_date":"2033-04-24","underlying":"Class B Common Stock","underlying_shares":20023},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804175,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":23986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2023, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":23986,"derivative":{"exercise_price":1.53,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":23986},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804174,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":23986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2023, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.53,"expiration_date":"2033-01-17","underlying":"Class B Common Stock","underlying_shares":23986},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804173,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":25310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":25310,"derivative":{"exercise_price":2.51,"expiration_date":"2027-02-15","underlying":"Common Stock","underlying_shares":25310},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804172,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":25310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.51,"expiration_date":"2027-02-15","underlying":"Class B Common Stock","underlying_shares":25310},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804171,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":266311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":266311,"derivative":{"exercise_price":2.51,"expiration_date":"2027-02-15","underlying":"Common Stock","underlying_shares":266311},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804170,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":266311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.51,"expiration_date":"2027-02-15","underlying":"Class B Common Stock","underlying_shares":266311},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804169,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":1224152,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":1224152},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804168,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A-1 Preferred Stock","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":880802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A-1 Preferred Stock is convertible into shares of Class B Common Stock on a 1:2.418 basis and has no expiration date. The Series A-1 Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A-1 Preferred Stock is convertible into shares of Class B Common Stock on a 1:2.418 basis and has no expiration date. The Series A-1 Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the IPO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A-1 Preferred Stock is convertible into shares of Class B Common Stock on a 1:2.418 basis and has no expiration date. The Series A-1 Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the IPO."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":364268},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804167,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Founders Preferred Stock","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":366004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":366004},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804166,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":1020742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":1020742},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804165,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":341191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":341191,"derivative":{"exercise_price":17,"expiration_date":"2036-04-15","underlying":"Common Stock","underlying_shares":341191},"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804164,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":1224152,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."}],"balance_after":1224152,"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804163,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":1224152,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}},{"id":804162,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51876,"kind":"person","name":"Luo Yuling","position":1,"cik":"0002126941","reported_name":"Luo Yuling","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2026-04-21T00:33:59.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":1224152,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Common Stock and Founders Preferred Stock are convertible into shares of Class B Common Stock on a 1:1 basis and have no expiration date. The Class A Common Stock and Founders Preferred Stock automatically converted into shares of Class B Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock (the \"IPO\")."}],"balance_after":1224152,"source":{"system":"sec-edgar","filing":"0002126941-26-000004","document":"form4-04212026_120453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2104204/000212694126000004/form4-04212026_120453.xml","form_type":"4"}}],"next_cursor":"2026-04-21T00:33:59.000000Z,804162"}